1. Market Research
  2. > All Companies
  3. > Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2014

  • October 2014
  • -
  • Global Markets Direct
  • -
  • 36 pages

Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Concert Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Concert Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Concert Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Concert Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Concert Pharmaceuticals, Inc.’s pipeline products

Reasons to buy

- Evaluate Concert Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Concert Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Concert Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Concert Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Concert Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Concert Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Concert Pharmaceuticals, Inc. Snapshot 5
Concert Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Concert Pharmaceuticals, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Concert Pharmaceuticals, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pipeline Products - Out-Licensed Products 11
Out-Licensed Products/Combination Treatment Modalities 12
Concert Pharmaceuticals, Inc. - Pipeline Products Glance 13
Concert Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Concert Pharmaceuticals, Inc. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Concert Pharmaceuticals, Inc. - Drug Profiles 17
CTP-499 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
CTP-354 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
C-10068 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
CTP-221 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
D-Ivacaftor 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
D-Praziquantel 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
C-10291 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
Concert Pharmaceuticals, Inc. - Pipeline Analysis 25
Concert Pharmaceuticals, Inc. - Pipeline Products by Target 25
Concert Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 26
Concert Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 27
Concert Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 28
Concert Pharmaceuticals, Inc. - Recent Pipeline Updates 29
Concert Pharmaceuticals, Inc. - Dormant Projects 33
Concert Pharmaceuticals, Inc. - Locations And Subsidiaries 34
Head Office 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 36
Disclaimer 36

List of Tables

Concert Pharmaceuticals, Inc., Key Information 5
Concert Pharmaceuticals, Inc., Key Facts 5
Concert Pharmaceuticals, Inc. - Pipeline by Indication, 2014 8
Concert Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 9
Concert Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 10
Concert Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2014 11
Concert Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 12
Concert Pharmaceuticals, Inc. - Phase II, 2014 13
Concert Pharmaceuticals, Inc. - Phase I, 2014 14
Concert Pharmaceuticals, Inc. - Preclinical, 2014 15
Concert Pharmaceuticals, Inc. - Discovery, 2014 16
Concert Pharmaceuticals, Inc. - Pipeline by Target, 2014 25
Concert Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 26
Concert Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 27
Concert Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 28
Concert Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 29
Concert Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 33

List of Figures

Concert Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2014 7
Concert Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 9
Concert Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 10
Concert Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2014 11
Concert Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2014 25
Concert Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2014 26
Concert Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2014 27
Concert Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014 28

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Partnerships, Licensing, Investments and M&A Deals and Trends for 2014 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for 2014 in Pharmaceuticals

  • $ 3 500
  • Company report
  • May 2015
  • by Global Data

Partnerships, Licensing, Investments and M&A Deals and Trends for 2014 in Pharmaceuticals Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for 2014 in Pharmaceuticals” ...

Liver Cancer - Pipeline Review, H1 2015

Liver Cancer - Pipeline Review, H1 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Markets Direct

Liver Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2015’, provides an overview of the Liver Cancer’s therapeutic pipeline. This report ...

Multiple Myeloma (Kahler%s Disease) - Pipeline Review, H1 2015

Multiple Myeloma (Kahler%s Disease) - Pipeline Review, H1 2015

  • $ 2 500
  • Company report
  • June 2015
  • by Global Markets Direct

Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015’, provides an overview of the Multiple ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.